Palvella Therapeutics (PVLA) Other Non-Current Assets (2015 - 2023)

Palvella Therapeutics (PVLA) has 9 years of Other Non-Current Assets data on file, last reported at $287000.0 in Q3 2023.

• On a quarterly basis, Other Non-Current Assets fell 78.04% year-over-year to $287000.0 in Q3 2023; TTM through Sep 2023 was $287000.0, a 78.04% decrease from a year earlier, with the FY2022 full-year figure at $1.4 million, down 52.86% from the prior year.
• Other Non-Current Assets for Q3 2023 stood at $287000.0, down from $1.1 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for PVLA reached as high as $11.5 million in Q2 2019 and fell as low as $287000.0 in Q3 2023.
• Historically, Other Non-Current Assets has averaged $2.9 million across 5 years, with a median of $2.4 million in 2022.
• Across the five-year window, Other Non-Current Assets surged 8806.98% in 2019 and tumbled 82.81% in 2020, its largest moves.
• Year by year, Other Non-Current Assets stood at $3.1 million in 2019, then grew by 5.18% to $3.3 million in 2020, then fell by 12.24% to $2.9 million in 2021, then tumbled by 52.86% to $1.4 million in 2022, then plunged by 79.04% to $287000.0 in 2023.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $287000.0 in Q3 2023, $1.1 million in Q2 2023, and $1.3 million in Q1 2023.